ResMed CEO Michael J. Farrell disposes of common shares worth $1,129,744.86

Bitget2026/10/08 21:32

ResMed Chairman and CEO Michael J. Farrell exercised options for 4,991 shares at USD 146.34 on Oct. 7, 2026. He sold 4,991 shares the same day at a weighted average price of USD 226.3349. Directly held stake fell to 479,803 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000943819-26-000085), on October 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

DeFi Development Raises CHAD Dividend Yield to 14% on Nasdaq-Listed Solana

Cointime•2026/10/15 15:59

Grayscale Announces New Partnership! 11 Altcoins Listed! Here Are the Details

BitcoinSistemi•2026/10/15 15:51

Mastercard brings stablecoin balances into traditional banking and card payments

Cointelegraph•2026/10/15 15:48

Nasdaq Experiences Network Issues, Customers May Encounter Data Loss

Cointime•2026/10/15 15:38